| Perry Anthony Chapdelaine Jr, MD | |
|
229 Ward Circle, Suite B12, Brentwood, TN 37027-7518 | |
| (615) 377-6767 | |
| (615) 377-6768 |
| Full Name | Perry Anthony Chapdelaine Jr |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
| Location | 229 Ward Circle, Brentwood, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114936770 | NPI | - | NPPES |
| 4071527 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | MD0000020838 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Perry Anthony Chapdelaine Jr, MD 229 Ward Circle, Suite B12, Brentwood, TN 37027-7518 Ph: (615) 377-6767 | Perry Anthony Chapdelaine Jr, MD 229 Ward Circle, Suite B12, Brentwood, TN 37027-7518 Ph: (615) 377-6767 |
News Archive
Rigel Pharmaceuticals, Inc. today announced that R348, its ophthalmic JAK/SYK inhibitor, did not meet the primary or secondary endpoints in a recently completed Phase 2 clinical study in patients with dry eye disease.
Research that provides a new understanding as to why ferrets are similar to humans is set to have major implications for the development of novel drugs and treatment strategies.
You've likely heard about being in the right place at the wrong time, but what about having the right genes in the wrong environment? In other words, could a genetic mutation (or allele) that puts populations at risk for illnesses in one environmental setting manifest itself in positive ways in a different setting?
As wise as the counsel to "finish what you've started" may be, it is also sometimes critically important to do just the opposite - stop.
St. Jude Medical, Inc. today announced European CE Mark approval and first implants of its Fortify™ and Fortify ST implantable cardioverter defibrillators (ICD) and Unify™ cardiac resynchronization therapy defibrillator (CRT-D). The devices will be fully launched in Europe later this spring, and U.S. versions of the Fortify ICD and Unify CRT-D are expected to be launched later this year. The reduced size of these new devices compared to those of previous generations creates the smallest available device footprint in the industry.
› Verified 2 days ago
Dr. David Meadow Ferriss Jr., MD, MPH Preventive Medicine Medicare: Medicare Enrolled Practice Location: 481 Sterns Xing, Brentwood, TN 37027 Phone: 615-260-4958 | |
Dr. Richard Mark Lachiver, MD, MPH Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1860 Westbury Ct, Brentwood, TN 37027 Phone: 615-372-3508 Fax: 615-372-3640 | |
Dr. Richard Vatt, DO Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 5301 Virginia Way, Suite 200, Brentwood, TN 37027 Phone: 630-263-3050 | |
Oluyomi Faparusi Sr., M.D., J.D., PH.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1274 Wheatley Forest Dr, Brentwood, TN 37027 Phone: 410-375-9817 | |
Robin Richard, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 9114 Brentmeade Blvd, Brentwood, TN 37027 Phone: 615-370-5907 |